LCQ LCQ in Specific Patient Populations 2

Question 1

How does LCQ performance differ in patients with neurogenic cough compared to other chronic cough etiologies?

Accepted Answer

LCQ scores are similarly reduced, reflecting the severe QoL burden of neurogenic cough

Answer

Patients with neurogenic (hypersensitivity) cough demonstrate similarly reduced LCQ scores as other chronic cough patients, reflecting equivalent quality of life burden.

Question 2

In interstitial lung disease (ILD) patients with chronic cough, which LCQ domain tends to show the greatest impairment?

Accepted Answer

Physical

Answer

In ILD patients with chronic cough, the physical domain tends to show the greatest impairment due to coexisting breathlessness, fatigue, and exercise limitation.

Question 3

Can the LCQ be used to assess chronic cough in patients with lung cancer?

Accepted Answer

Yes — it has been applied in oncology settings to measure cough-related QoL

Answer

The LCQ has been used in oncology settings to evaluate cough-related quality of life in lung cancer patients as a patient-reported outcome measure.

Question 4

What challenge arises when using the LCQ in elderly patients with multiple comorbidities?

Accepted Answer

Difficulty attributing QoL impairment to cough alone versus other conditions

Answer

In elderly patients with multiple comorbidities, it can be difficult to determine whether LCQ score reductions are attributable to cough alone or confounded by other health conditions.

Question 5

Has the LCQ been validated in non-English-speaking US patient populations?

Accepted Answer

Yes — translations in multiple languages have been validated

Answer

Validated translations of the LCQ exist in multiple languages including Spanish, which is particularly relevant for the diverse US patient population.

LCQ - Leicester Cough Questionnaire Practice Test

LCQ - Leicester Cough Questionnaire Practice Test

LCQ LCQ in Specific Patient Populations 2